1.14
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
51.55%
4.5574
|
3.0072 | 3.1586 | 2.5233 | 2.3898 |
| Costs And Expenses |
24.20%
7.196
|
5.7939 | 5.6906 | 4.8507 | 6.0375 |
| Operating Income/Loss |
24.20%
-7.196
|
-5.7939 | -5.6906 | -4.8507 | -6.0375 |
| Nonoperating Income/Loss |
89.55%
0.2654
|
0.14 | 0.3954 | 0.4068 | 0.5896 |
| Net Income/Loss |
22.58%
-6.9307
|
-5.6539 | -5.2952 | -4.4439 | -5.4479 |
| Basic Average Shares |
188.48%
12.23
|
4.2401 | 0.5001 | 3.162 | 1.6088 |
| Diluted Average Shares |
188.48%
12.23
|
4.2401 | 0.5001 | 3.162 | 1.6088 |
| Basic Earnings Per Share |
57.14%
-0.57
|
-1.33 | -0.53 | -1.41 | -3.39 |
| Diluted Earnings Per Share |
57.14%
-0.57
|
-1.33 | -0.53 | -1.41 | -3.39 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):